Coronavirus Update: Lilly To Seek EUA For Olumiant

Plus: Gilead Agrees European Procurement Deal On Veklury

Hot on the heels of positive news from its monoclonal antibody treatment, Lilly aims to seek emergency authorization for anti-inflammatory treatment Olumiant.  

Indianapolis - Circa April 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals IV
Lilly has reported encouraging data from Olumiant's combination with Gilead's Veklury

More from Business

More from Scrip